YAP1/OCT4: Small Molecule Inhibitors of the Protein-protein Interaction of YAP1 and OCT4 to Treat Cancer

Disruption of the OCT4-YAP1 interaction suppresses Sox2 expression as well as certain metabolic genes, preventing the self-renewal of stem-like cells thus preventing tumor initiation, progression, drug resistance and metastasis. Highly potent and selective disruptors of the Oct4-YAP1 interaction were identified by researchers here at Moffitt. These compounds can be developed into anti-cancer therapies for lung cancer and possibly other malignancies.

FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE

Contact

Haskell Adler PhD MBA
Senior Licensing Manager
Haskell.Adler@Moffitt.org
(813) 745-6596